Larvol Delta - Chimeric-Antigen-Receptor-CAR-T-Cells-With-a-Chlorotoxin-TumorTargeting-Domain-for-the-Treatment-of-MMP2-Recurrent-or-Progressive-Glioblastoma

CHM 1101 - Chimeric Therap

http://clinicaltrials.gov/ct2/show/NCT04214392

Feb 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next